Showing results (101-110 of 4,751) with videos related to
Sort By:
Pageof 476
Ebiomedicine|April 10, 2022
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccinesLu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, et al.Ebiomedicine|February 3, 2022
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years oldFrancesco Nicoli, Emmanuel Clave, Kerstin Wanke, et al.Ebiomedicine|February 5, 2022
Nuclear receptors in renal health and diseaseZhi-Lin Luan, Cong Zhang, Wen-Hua Ming, et al.Ebiomedicine|March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19Fabienne Venet, Morgane Gossez, Frank Bidar, et al.Ebiomedicine|March 29, 2022
Coagulation factor protein abundance in the pre-septic state predicts coagulopathic activities that arise during late-stage murine sepsisDouglas M Heithoff, Genaro Pimienta, Scott P Mahan, et al.Ebiomedicine|April 2, 2022
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individualsNicolás A Muena, Tamara García-Salum, Catalina Pardo-Roa, et al.Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.Ebiomedicine|March 1, 2022
Ageing with HIV: Challenges and biomarkersBerta Rodés, Julen Cadiñanos, Andrés Esteban-Cantos, et al.Ebiomedicine|March 1, 2022
Genetic validation of neurokinin 3 receptor antagonists for ischemic heart disease prevention in men - A one-sample Mendelian randomization studyC M SchoolingEbiomedicine|January 22, 2022
SIDT1 plays a key role in type I IFN responses to nucleic acids in plasmacytoid dendritic cells and mediates the pathogenesis of an imiquimod-induced psoriasis modelMaría Morell, Nieves Varela, Casimiro Castillejo-López, et al.Pageof 476